Tomomi Ikemoto

541 total citations
37 papers, 416 citations indexed

About

Tomomi Ikemoto is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Tomomi Ikemoto has authored 37 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Organic Chemistry, 23 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Tomomi Ikemoto's work include Chemical Synthesis and Analysis (11 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Chemical Synthesis and Reactions (5 papers). Tomomi Ikemoto is often cited by papers focused on Chemical Synthesis and Analysis (11 papers), Bioactive Compounds and Antitumor Agents (5 papers) and Chemical Synthesis and Reactions (5 papers). Tomomi Ikemoto collaborates with scholars based in Japan and United States. Tomomi Ikemoto's co-authors include Naohiro Fukuda, Tatsuya Ito, Mitsuhiro Wakimasu, Toshiaki Nagata, Masato Ishida, Hiroyuki Hatano, Tetsuji Kawamoto, Tatsuya Itô, Minoru Izumi and Wilbur K. Milhous and has published in prestigious journals such as The Journal of Organic Chemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Tomomi Ikemoto

36 papers receiving 393 citations

Peers

Countries citing papers authored by Tomomi Ikemoto

Since Specialization

Citations

This map shows the geographic impact of Tomomi Ikemoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomomi Ikemoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomomi Ikemoto more than expected).

Fields of papers citing papers by Tomomi Ikemoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomomi Ikemoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomomi Ikemoto. The network helps show where Tomomi Ikemoto may publish in the future.

Co-authorship network of co-authors of Tomomi Ikemoto

This figure shows the co-authorship network connecting the top 25 collaborators of Tomomi Ikemoto. A scholar is included among the top collaborators of Tomomi Ikemoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomomi Ikemoto. Tomomi Ikemoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rhodium-Catalyzed Highly Enantioselective Hydrogenation of a Tetrasubstituted Enamine 2021 ·Organic Process Research & Development ·Masatoshi Yamada, Tomoaki Kato, Tomomi Ikemoto, (unknown)	1
2	Practical Preparation of a 1,3,5-Trisubstituted Pyridazin-4(1H)-one Using Selective C₁ Unit Insertion and Cyclization 2019 ·Organic Process Research & Development ·(unknown), Naohiro Fukuda, (unknown), Tomomi Ikemoto	3
3	Development of a Practical Synthesis of a Peripherally Selective Noradrenaline Reuptake Inhibitor Possessing a Chiral 6,7-trans-Disubstituted-1,4-oxazepane as a Scaffold 2017 ·Organic Process Research & Development ·(unknown), (unknown), (unknown), (unknown), Tomomi Ikemoto	4
4	Design and synthesis of a novel 2-oxindole scaffold as a highly potent and brain-penetrant phosphodiesterase 10A inhibitor 2015 ·Bioorganic & Medicinal Chemistry ·Masato Yoshikawa, Haruhi Kamisaki, Jun Kunitomo, Hideyuki Oki, Hironori Kokubo, (unknown), Tomomi Ikemoto, Kosuke Nakashima, (unknown), (unknown), Haruhide Kimura, Takahiko Taniguchi	21
5	Safe and convenient nitroxyl radical and imide dual catalyzed NaOCl oxidation of alcohols to aldehydes/ketones 2015 ·Tetrahedron Letters ·Naohiro Fukuda, Minoru Izumi, Tomomi Ikemoto	9
6	Convenient and Eco-Friendly Method for the Conversion of Benzylic Alcohols into Aldehydes, Ketones, and Carboxylic Acids Using NaOCl without any Additives in 1,2-Dimethoxyethane 2013 ·Synlett ·Tomomi Ikemoto, Naohiro Fukuda, (unknown), (unknown), Keisuke Majima	7
7	Development of a Scalable Synthesis of a Vascular Endothelial Growth Factor Receptor-2 Kinase Inhibitor: Efficient Construction of a 6-Etherified [1,2,4]Triazolo[1,5-a]pyridine-2-amine Core 2013 ·Organic Process Research & Development ·(unknown), Naohiro Fukuda, Toshiaki Nagata, (unknown), Tomomi Ikemoto	10
8	Imide-Catalyzed Oxidation System: Sulfides to Sulfoxides and Sulfones 2010 ·The Journal of Organic Chemistry ·Naohiro Fukuda, Tomomi Ikemoto	84
9	ChemInform Abstract: Versatile and Fluoride‐Free Cyanation of Alkyl Halides and Sulfonates with Trimethylsilyl Cyanide. 2009 ·ChemInform ·(unknown), (unknown), Tomomi Ikemoto	1
10	Versatile and Fluoride-FreeCyanation of Alkyl Halides and Sulfonates with Trimethylsilyl Cyanide 2009 ·Synlett ·Tomomi Ikemoto, (unknown), (unknown)	6
11	Preparation of a 1-Unsubstituted 2,3-Dihydro-1-benzazepine Derivative 2007 ·Heterocycles ·(unknown), Tomomi Ikemoto, Tatsuya Ito, (unknown), (unknown)	4
12	Practical Synthesis of an Orally Active CCR5 Antagonist, 7-{4-[2-(Butoxy)- ethoxy]phenyl}-N-(4-{[methyl(tetrahydro-2H-pyran-4-yl)amino]methyl}phenyl)- 1-propyl-2,3-dihydro-1H-1-benzazepine-4-carboxamide 2005 ·Organic Process Research & Development ·Tomomi Ikemoto, Tatsuya Ito, (unknown), (unknown), (unknown)	19
13	Unusual asymmetric oxidation of sulfide; the diastereoselective oxidation of prochiral sulfide-chiral acid salt with hydrogen peroxide without metal 2005 ·Tetrahedron ·Tomomi Ikemoto, (unknown), Tatsuya Ito, H. TAWADA	5
14	Facile synthesis of 7–10 membered rings by intramolecular condensation using dialkylcarbonate as solvent 2004 ·Tetrahedron Letters ·Tomomi Ikemoto, Tatsuya Ito, (unknown), (unknown)	14
15	Practical synthesis of (R)-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-hydroxyphenyl)hexanoic acid: a key intermediate for a therapeutic drug for neurodegenerative diseases 2003 ·Tetrahedron Asymmetry ·Tatsuya Ito, Tomomi Ikemoto, (unknown), (unknown), (unknown)	15
16	Convenient efficient synthesis of TAK-779, a nonpeptide CCR5 antagonist: development of preparation of various ammonium salts using trialkylphosphite and N-halogenosuccinimide 2001 ·Tetrahedron ·Tomomi Ikemoto, (unknown), (unknown), Mitsuhiro Wakimasu, (unknown)	6
17	Development of a New Synthetic Route of a Non-Peptide CCR5 Antagonist, TAK-779, for Large-Scale Preparation 2000 ·Organic Process Research & Development ·Tomomi Ikemoto, Tatsuya Ito, Hideo Hashimoto, (unknown), (unknown), (unknown), Mitsuhiro Wakimasu, (unknown)	9
18	A Practical Synthesis of the Chronic Renal Disease Agent, 4,5-Dihydro-3H-1,4,8b-triazaacenaphthylen-3-one Derivatives, Using Regioselective Chlorination of Ethyl 5-methylimidazo[1,2-a]pyridine-3-carboxylate with N-Chlorosuccinimide 2000 ·Tetrahedron ·Tomomi Ikemoto, Tetsuji Kawamoto, (unknown), (unknown), Mitsuhiro Wakimasu	8
19	A Practical Method for Optical Resolution of Racemic Alcohols or Esters via Lipase-Catalyzed Transformation and Sulfation 2000 ·Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), Mitsuru Kawada, Tatsuya Ito, Tomomi Ikemoto, (unknown), (unknown)	17
20	Phosphorylation of Nucleosides with Phosphorus Oxychloride in Trialkyl Phosphate. 1995 ·Chemical and Pharmaceutical Bulletin ·Tomomi Ikemoto, (unknown), Hiroyuki Hatano, (unknown), Masato Ishida, (unknown)	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact